All Stories

  1. Profile of inhaled levodopa and its potential in the treatment of Parkinson’s disease: evidence to date
  2. Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial
  3. Randomized controlled trial of deutetrabenazine for tardive dyskinesia
  4. Cerebellar Disease
  5. Three Cases of Levodopa-Resistant Parkinsonism After Radiation Therapy
  6. Mood and Quality of Life Self-Report Preliminary Outcomes for the Parkinson's Disease-Cognitive Rehabilitation for Executive Functioning Program (PD-CoRE)
  7. 4.14 A PILOT STUDY OF SD-809 (DEUTETRABENAZINE) IN TICS ASSOCIATED WITH TOURETTE'S DISORDER
  8. Treatment-refractory Tourette Syndrome
  9. GPi Oscillatory Activity Differentiates Tics from the Resting State, Voluntary Movements, and the Unmedicated Parkinsonian State
  10. Prediction of STN-DBS Electrode Implantation Track in Parkinson's Disease by Using Local Field Potentials
  11. levodopa formulations
  12. A Wireless Sensor Interface for the Quantification of Tremor Using Off the Shelf Components
  13. Design challenges for stimulation trials of Tourette's syndrome
  14. SPG11Mutations Associated With a Complex Phenotype Resembling Dopa-Responsive Dystonia
  15. Intraoperative macroelectrode local field potential recordings in Essential Tremor
  16. Improvement in dystonic camptocormia following botulinum toxin injection to the external oblique muscle
  17. Simultaneous improvement of tics and parkinsonism after pallidal DBS
  18. Effects of deep brain stimulation in relatively young-onset multiple system atrophy Parkinsonism
  19. Habituation and rebound to thalamic deep brain stimulation in long-term management of tremor associated with demyelinating neuropathy
  20. Radiofrequency lesioning through deep brain stimulation electrodes: A pilot study of lesion geometry and temperature characteristics
  21. The safety and efficacy of thalamic deep brain stimulation in essential tremor: 10 years and beyond
  22. Rechargeable Deep Brain Stimulation Implantable Pulse Generators in Movement Disorders: Patient Satisfaction and Conversion Parameters
  23. Tetrabenazine for treatment of chorea associated with Huntington's disease and other potential indications
  24. Analysis ofCYP2D6genotype and response to tetrabenazine
  25. Globus pallidus deep brain stimulation for refractory idiopathic restless legs syndrome
  26. Introduction to dystonia
  27. Use of Rechargeable DBS Implantable Pulse Generators in Patients with Movement Disorders: Patient Satisfaction and Stimulation Parameters (P02.237)
  28. Long-Term Neuropsychological Follow-Up in Pallidal Stimulation for Medically-Refractory Tourette Syndrome (P06.037)
  29. Diagnostic Reliability of DaTscan in Movement Disorders (P03.125)
  30. Deep Brain Stimulation for Tourette Syndrome: Target Selection
  31. A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins
  32. Topiramate in Treatment of Tourette Syndrome
  33. Camptocormia as a presentation of generalized inflammatory myopathy
  34. A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome
  35. Tourette Syndrome
  36. Internet dyskinesias in Parkinson’s disease
  37. An elderly lady with ataxia and neuropathy
  38. Mutation analysis of the parkin and PINK1 genes in American Caucasian early-onset Parkinson disease families
  39. Malignant Tourette syndrome
  40. The effects of subthalamic nucleus deep brain stimulation on parkinsonian tremor
  41. Exploring the relationship between essential tremor and Parkinson's disease
  42. Reply: Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome
  43. Motor symptoms in Parkinson's disease
  44. EPIDEMIOLOGY AND PATHOGENESISIntroduction to Dystonia
  45. Globus pallidus deep brain stimulation in dystonia
  46. Re-emergence of childhood stuttering in Parkinson's disease: A hypothesis